Authors
The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.
No takes yet. Share an insight, caveat, or question.
Jansson et al. (2018) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: